Navigation Links
CryoLife Enhances Management Team with Promotions
Date:1/4/2012

e areas.  These future events may not occur as and when expected, if at all, and, together with the Company's business, are subject to various risks and uncertainties.  These risks and uncertainties include that the regulatory approval process for our products and the development of new products can be time consuming and costly, and may not ultimately prove to be successful.  Even if new regulatory approvals are obtained for BioGlue, BioFoam and/or PerClot, or new products are developed, these developments may not lead to increased sales or revenue growth for a number of reasons, including those discussed below.  Based on changing conditions in our Company and in the economy generally, management may decide to terminate its pursuit of regulatory approvals for certain products or the development of any products in our pipeline at any time, and our current plans and timeline for regulatory approvals and the development of new products may be altered.  Also, even if the requisite regulatory approvals are obtained for our products, the products may not provide the anticipated medical benefits, may not ultimately be accepted by physicians and patients, and competing products and solutions may be developed or may already exist that gain market footholds and adversely impact future sales of our products.  The potential market for any of our products could also be impacted by a number of other factors, including the effectiveness and relative cost of competing products, the impact of future surgical innovations and medical breakthroughs and the perceptions of surgeons and other medical professionals.  Continuing negative economic conditions could accentuate the impact of price on the ability of our products to compete.  Past experience and trends regarding the growth and/or margins related to any of our products are not necessarily reflective of future performance, and sales and margins may decline due to any of the fact
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
2. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
3. CryoLife Reports Record Quarterly Revenues of $28.2 Million
4. CryoLife to Present at Upcoming Investor Conferences in New York
5. CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference
6. CryoLife Provides Initial 2010 Financial Guidance
7. CryoLife Enters into Worldwide Distribution and Manufacturing Agreements with Starch Medical for Novel Hemostatic Agent
8. CryoLife Receives Japanese Regulatory Approval for BioGlue Surgical Adhesive
9. CryoLife Announces Release Date and Teleconference Call Details for 2010 Third Quarter Financial Results
10. CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
11. CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 Commenting on GSK,s ... CFO Simon Dingemans reveals sales rose during ... in line with expectations. Ahead of a November R&D ... innovation. The interview and transcript are available ... in-depth interviews, documentaries and webcasts with senior company executives. ...
(Date:7/29/2015)... Schein, Inc. (NASDAQ: HSIC ), the world,s ... to office-based dental, animal health and medical practitioners, ... Net sales for the quarter ended June ... 0.5% compared with the second quarter of 2014.  ... and a 7.0% decline related to foreign currency ...
(Date:7/29/2015)... PITTSBURGH , July 29, 2015 /PRNewswire/ ... it received regulatory clearance from the European Commission under ... acquisition of Perrigo Company plc (NYSE: PRGO ; ... J. Coury commented, "Today marks yet another important ... Perrigo and serves as further affirmation of the sound ...
Breaking Medicine Technology:Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9
... Details Statistically Significant Clinical Results for,SB-509 in ... June 22, 2007 /PRNewswire-FirstCall/ -- Sangamo,BioSciences, Inc. ... clinical data from its ZFP Therapeutic(TM) program ... Diabetes Association,(ADA). As disclosed in an oral ...
... BOCA RATON, Fla., June 25, 2007 /PRNewswire/ -- ... than half of women whose male,partners have symptoms ... attribute them to the normal course of,aging. The ... male,partner's symptoms of low testosterone negatively impact their,relationship, ...
Cached Medicine Technology:Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 2Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 3Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 4Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 5Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 6Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 7Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 8Sangamo BioSciences Announces Presentation of Phase 1 ZFP,Therapeutic Data at American Diabetes Association Meeting 9New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 2New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 3New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 4New Poll Shows Men, Women Incorrectly Blame Symptoms of Low,Testosterone on Normal Aging 5
(Date:7/29/2015)... ... , ... For the second year in a row, the management and staff ... fastest growing companies in Jacksonville. This annual list is compiled by the Jacksonville Business ... of Vast Bridges staffers were on hand to receive the award naming the company ...
(Date:7/29/2015)... ... 29, 2015 , ... Fastline Publications, Inc., will be featured ... , Fastline is dedicated to quality agricultural advertising, both in print and online. ... freshest searchable agriculture equipment database in the world. The site has equipment listings ...
(Date:7/29/2015)... ... , ... Employee Fiduciary, LLC announces the launch of its new, online Financial ... plans administered, years in business, and credentials of all Employee Fiduciary financial advisor ... Employee Fiduciary. A search can be done by zip code so a plan sponsor ...
(Date:7/29/2015)... MO (PRWEB) , ... July 29, 2015 , ... ... of a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to ... birth defects research at their website, the Zofran Birth Defects Lawsuit Center. , ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... global provider of life insurance, annuities, employee benefits and asset management, has joined ... inclusive sporting event taking place in Charlotte, North Carolina on October 2-4, 2015. ...
Breaking Medicine News(10 mins):Health News:Vast Bridges Continues Its Swift Growth 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3
... experts are warning grocery-store pharmacies that antibiotics giveaways ... want to help customers and save them money ... Society of America (IDSA) says, they should offer ... & Shop, and other grocery stores have recently ...
... care, one expert says , , FRIDAY, Jan. 16 (HealthDay News) ... with postpartum depression can be treated effectively by professionals or ... find. , Both reports, published in the Jan. 16 online ... and caring communication can help new mothers deal with their ...
... Axium Healthcare Pharmacy, one of,the nation,s largest independent ... Golden 100 Companies for 2008." This is the fourth,consecutive ... "We are pleased by this recognition," ... our dedicated employees we have experienced,continued growth within our ...
... 16 Several individuals and organizations were honored at the ... at the Hyatt Regency Princeton. NJHA,s 2009 ... Lloyd, FACHE, from Oceanport, president and CEO of Meridian Health ... service and leadership to Meridian Health, its patients and communities ...
... Shield of Michigan,announced a series of actions today to preserve ... health plans that could exceed a,cumulative total of $1 billion ... J. Loepp, BCBSM president and CEO, this morning announced a,workforce ... Network HMO,subsidiary over the next 60 days - and subsequent ...
... Health and the University of Colorado Denver have discovered a ... acute lung injury. Acute lung injury (ALI) is often caused ... in the blood, and fluid in the lungs. It is ... afflicting almost 200,000 people in the United States each year, ...
Cached Medicine News:Health News:Free antibiotics: The wrong prescription for cold and flu season 2Health News:Caring Counseling May Ease Postpartum Depression 2Health News:Caring Counseling May Ease Postpartum Depression 3Health News:Hospital Association Presents Awards for Commitment to Healthcare 2Health News:Hospital Association Presents Awards for Commitment to Healthcare 3Health News:Hospital Association Presents Awards for Commitment to Healthcare 4Health News:Facing Large and Uncontrollable Financial Losses on Individual Policies, Blue Cross Blue Shield of Michigan Will Cut Up to 1000 Jobs in 2009, Reduce Spending and Seek Rate Increases on Individual Plans 2Health News:Facing Large and Uncontrollable Financial Losses on Individual Policies, Blue Cross Blue Shield of Michigan Will Cut Up to 1000 Jobs in 2009, Reduce Spending and Seek Rate Increases on Individual Plans 3Health News:Gene associated with reduced mortality from acute lung injury 2
... Test is a qualitative enzyme immunoassay ... Paul-Bunnell heterophil, Epstein-Barr virus capsid antigen ... in conjunction with Mono-G Test, it ... of infectious (EBV) mononucleosis and presumptive ...
... ImmunoWELL VCA IgG Test is an ELISA method ... Epstein-Barr Virus viral capsid antigen (VCA) in human ... in conjunction with other testing such as the ... early antigen tests and/or heterophile tests, the results ...
... The ImmunoWELL VZV IgG Test ... the qualitative detection of IgG ... Test results are used as,an ... or infection. Immune status may ...
... ImmunoDOT Thyroid Autoimmunity Test is an enzyme ... of autoantibodies against human thyroglobulin and human ... whole blood and is used as an ... Autoimmune thyroid gland disorders are characterized by ...
Medicine Products: